Category Archives: oncotarget
“I sincerely apologise:” UK cancer researcher calls for retraction of his work years after it’s flagged on PubPeer
A cancer researcher in England says he will be retracting a 2011 paper after acknowledging “unacceptable” manipulation of some of the figures in the article. Richard Hill, of the University of Portsmouth, this week agreed to retract the article, “DNA-PKcs binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death,” which appeared … Continue reading “I sincerely apologise:” UK cancer researcher calls for retraction of his work years after it’s flagged on PubPeer
Posted by in cancer biology, image manipulation, oncotarget
When a journal is delisted, authors pay a price
Shocked, confused, disappointed — these are the reactions of authors who recently published in a cancer journal that was delisted by a company that indexes journals. Recently, Clarivate Analytics announced it would discontinue indexing Oncotarget after the first few issues of 2018 — as a result, the journal would not receive a current impact factor. The company … Continue reading When a journal is delisted, authors pay a price
Posted by in impact journals, oncotarget
Indexing company praises cancer journal, then kicks it out
A company that indexes journals — which, in turn, designates their impact factors — has delisted Oncotarget, a cancer journal that was recently removed from MEDLINE. Just three months ago, on October 18, the indexing company Clarivate Analytics (formerly part of Thomson Reuters) named Oncotarget a “rising star” in the field of molecular biology and genetics. […]
The post Indexing company praises cancer journal, then kicks it out appeared first on Retraction Watch.
Posted by in impact journals, oncotarget
Lead author changes co-author’s name on a paper without his permission. Why?
Here’s a rather odd case: A postdoctoral researcher says his former boss changed his name on a paper without his permission. According to the postdoc, Antonio Herrera-Merchan, his principal investigator at University of Granada insisted on the name change to distance them both from a scandal in Herrera-Merchan’s previous lab. After publishing a paper in […]
The post Lead author changes co-author’s name on a paper without his permission. Why? appeared first on Retraction Watch.
Posted by in oncotarget, spain
Widely used U.S. government database delists cancer journal
The U.S. government biomedical research database MEDLINE no longer includes a cancer journal with a storied past. Starting August 2017, researchers looking up journals indexed in MEDLINE (which is accessed via PubMed) could no longer find new articles published by Oncotarget, once included on the now-defunct list of possibly predatory journals compiled by librarian Jeffrey […]
The post Widely used U.S. government database delists cancer journal appeared first on Retraction Watch.
Posted by in cancer biology, impact journals, oncotarget
“Authors’ negligence” causes “a plethora of data errors”
Sometimes, even a short notice catches our attention. Such was the case with a recent retraction issued by Oncotarget for a 2016 paper related to the genetics that drive cancer. Here’s the notice: Due to the authors’ negligence during the preparation of this manuscript for submission, it contains a plethora of data errors. Authors sincerely apologize […]
The post “Authors’ negligence” causes “a plethora of data errors” appeared first on Retraction Watch.
A “plethora of data errors” prompts authors to retract oncology paper
Researchers in China have retracted a 2016 cancer imaging paper because they introduced “a plethora of data errors” while preparing the article for submission. Although the retraction notice provides no details on what these errors are or how exactly they occurred, it does point the finger at the researchers, explaining that the data errors happened as a […]
The post A “plethora of data errors” prompts authors to retract oncology paper appeared first on Retraction Watch.
Posted by in china retractions, freely available, impact journals, oncology retractions, oncotarget
Prostate cancer paper flagged by ORI is retracted following PETA prompt
A federal investigation into a paper on prostate cancer has now led to a retraction. In an unusual twist, it happened following a request from the animal rights group People for the Ethical Treatment of Animals (PETA). In January, the Office of Research Integrity reported that corresponding author Dong Xiao “intentionally fabricated data” in an Oncotarget study of how a steroid inhibits […]
The post Prostate cancer paper flagged by ORI is retracted following PETA prompt appeared first on Retraction Watch.
Former Pitt cancer researcher admits to faking findings
A former researcher at the University of Pittsburgh inflated the number of mice used in his experiments, and faked data in a number of images in a paper reporting the results, according to the Office of Research Integrity (ORI). Dong Xiao admitting to having intentionally fabricated data contained in a paper entitled ‘Guggulsterone inhibits prostate cancer growth […]
The post Former Pitt cancer researcher admits to faking findings appeared first on Retraction Watch.